Drugs / RO6926496
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02281786 | Jan → Oct 2015 | — | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO6926496 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02281786 ↗ |
| Route | Intravenous | “single, ascending dose, intravenous administration” NCT02281786 ↗ |